BioCorRx Inc. (OTCMKTS:BICX) Short Interest Update

BioCorRx Inc. (OTCMKTS:BICX) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 7,100 shares, an increase of 222.7% from the February 28th total of 2,200 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average trading volume of 10,600 shares, the days-to-cover ratio is currently 0.7 days.

BioCorRx Stock Down 0.3 %

BICX traded down $0.00 during midday trading on Thursday, reaching $0.35. 136 shares of the company’s stock were exchanged, compared to its average volume of 14,177. The business has a 50-day simple moving average of $0.39 and a two-hundred day simple moving average of $0.37. BioCorRx has a one year low of $0.26 and a one year high of $1.50. The firm has a market capitalization of $5.58 million, a price-to-earnings ratio of -0.67 and a beta of 0.57.

BioCorRx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.